Vadim Bernard-Gauthier, PhD

Bayer Pharmaceuticals, Inc., Toronto, ON, Canada
Toronto, Ontario, Canada

Disclosure information not submitted.

Presentation(s):

• Paper 69 - UPDATED EFFICACY, SAFETY, AND TREATMENT DISCONTINUATION OUTCOMES OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TRK FUSION SARCOMAS

  Saturday, November 16, 2024
  8:00 AM – 9:00 AM PST